Is the aortic root dilated in obstructive sleep apnoea syndrome?

Archives of Cardiovascular Diseases

Volumn 101, Issue 6, 2008, Pages 391-397

  Meuleman, Catherine ^a   Boccara, Franck ^a   Nguyen, Xuan Lan ^a   Di Angelantonio, Emanuele ^a   Ederhy, Stéphane ^a   Janower, Sandra ^a   Dufaitre, Ghislaine ^a   Haddour, Nabila ^a   Boyer Chatenet, Louise ^a   Rakotonanahary, Dominique ^a   Fleury, Bernard ^a   Cohen, Ariel ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

Aortic root dilatation; Obstructive sleep apnoea syndrome; Pulse wave velocity

Indexed keywords

ADULT; AGE DISTRIBUTION; AORTA DISEASE; AORTA VALVE REGURGITATION; AORTIC ROOT DILATATION; ARTERIAL STIFFNESS; ARTICLE; CAROTID ARTERY PULSE; DISEASE DURATION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; POSITIVE END EXPIRATORY PRESSURE; PREDICTION; PREVALENCE; PULSE WAVE; SEX DIFFERENCE; SLEEP APNEA SYNDROME; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 54949085412     PISSN: 18752136     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.acvd.2008.06.007     Document Type: Article

References (37)

1. Young T, Palta M, Dempsey J, et al. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 1993;328:1230-5.
2. Young T, Peppard PE, Gottlieb DJ. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002;165:1217-39.
3. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378-84.
4. Mooe T, Rabben T, Wiklund U, et al. Sleep-disordered breathing in men with coronary artery disease. Chest 1996;109:659-63.
5. Schafer H, Koehler U, Ewig S, et al. Obstructive sleep apnea as a risk marker in coronary heart disease. Cardiology 1999;92:79-84.
6. Cormican LJ, Williams A. Sleep disordered breathing and its treatment in congestive in heart failure. Heart 2005;91:1265-70.
7. Laaban JP, Pascal-Sebaoun S, Bolch E, et al. Left ventricular dysfunction in patients with obstructive sleep apnea. Chest 2002;122:1133-8.
8. Yaggi Klar, Concato J, Kernan W, et al. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005;353:2034-41.
9. Phillips C, Hedner J, Berend N, et al. Diurnal and obstructive sleep apnea influences on arterial stiffness and central blood pressure in men. Sleep 2005;28:604-9.
10. Sampol G, Ramero O, Salas A, et al. Obstructive sleep apnea and thoracic aortic dissection. Am J Resp Crit Care Med 2003;168:1528-31.
11. Mansia G, De Backer G, Dominiczak A et al.; European Society of Hypertension; European Society of Cardiology 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Blood Press. 2007; 16(3):135-232.
12. Hanley AJ, Wagenknecht LE, D'Agostino Jr RB, Zinman B, Haffner SM. Identification of subjects with insulin resistance and beta-cell dysfunction using alternative definitions of the metabolic syndrome. Diabetes 2003;52:2740-7.
13. Sahn DJ, De Maria A, Kisslo J, et al. The committee on M-mode standardization of the American society of echocardiography; recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiographics measurements. Circulation 1978;58:1072-81.
14. Roman MJ, Devereux RB, Kramer-Fox R, et al. Two-dimensional echocardiographic aortic root dimensions in normal children and adults. Am J Cardiol 1989;64:507-12.
15. Zoghbi WA, Enriquez-Sarano M, Faster E, et al. Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003;16:777-802.
16. Schiller NB, Shah PM, crawford M, et al. Recommendations for quantification of the left ventricle by two-dimensional echocardiography: American Society of Echocardiography by committee on standards, Subcommittee on quantification of two-dimensional Echoacrdiograms. J Am Soc Echocardiogr 1989;2:358-67.
17. Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450-8.
18. Berger M, Haimowitz A, Van Tosh A, et al. Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave doppler ultrasound. J Am Coll Cardiol 1985;6:359-65.
19. Laurent S, Boutourye P, Asmar E, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001;37:1236-41.
20. Sleep-related breathing disorders in adults: recommandations for syndrome definition and measurement techniques in clinical research:th ereport of an American Academy of sleep Medicine Task Force. Sleep 1999; 22:667-89.
21. Meoli AL, Casey KR, Clark RW, et al. Hypopnea in sleep-disordered breathing in adults. Sleep 2001;24:469-70.
22. Johns MW. Daytime sleepiness, snoring and obstructive sleep apnea: the Epworth Sleepiness Scale. Chest 1993;103:30-6.
23. Reed CM, Richey PA, Pulliam DA, Somes GW. Aortic dimensions in tall men and women. Am J Cardiol 1993;71:608-10.
24. Vasan RS, Larson MG, Levy D. Determinants of echocardiographic aortic root size. The Framingham Heart Study. Circulation 1995;91:734-40.
25. Valdez RS, Motta JA, London E, et al. Evaluation of the echocardiogram as an epidemiologic tool in an asymptomatic population. Circulation 1979;60:921-9.
26. Tell GS, Rutan GH, Kronmal RA, et al. Correlates of blood pressure in community-dwelling older adults. Hypertension 1994;23:59-67.
27. Cistulli PA, Sullivan CE. Sleep-disordered breathing in Marfan's syndrome. Am Rev Respir Dis 1993;147:645-8.
28. Cistulli P, Wilcox I, Jeremy R, et al. Aortic root dilatation in Marfan's syndrome. A contribution from obstructive sleep apnea? Chest 1997;111:1763-6.
29. Verbraecken J, Paelinck B, Willemen M, et al. Aortic root diameter and nasal intermittent positive airway pressure treatment in Marfan's syndrome. Clin Genet 2003;63: 131.
30. Milleron O, Pilliere R, Foucher A, et al. Benefits of obstructive sleep apneoa treatment in coronary artery disease: a long-term follow-up study. Eur Heart J 2004;25:728-34.
31. Partinen M, Jamieson A, Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients. Mortality. Chest 1988;94:1200-4.
32. Marin JM, Carrizo SJ, Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnea-hypopnea syndrome with or without treatment with continuous positive airway presure: an observationnal study. Lancet 2005;365:1046-53.
33. Doherty LS, Kiely JL, Swan V, et al. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 2005;127: 2076-84.
34. Lehmann ED. Clinical value of aortic pulse wave velocity measurement. Lancet 1999;164:528-9.
35. Asmar R, Benetos A, Topouchian J, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement: validation and clinical applications studies. Hypertension 1995;26:485-90.
36. Nagahama H, Soejima M, Uenomachi H, et al. Pulse wave velocity as an indicator of atherosclerosis in obstructive sleep apnea syndrome. Intern Med 2004;43:184-8.
37. Tanriverdi H, Evrengul H, Kaftan A, et al. Effect of obstructive sleep apnea on aortic elastic parameters - relationship to left ventricular mass and function. Circ J 2006;70:737-43.